Expert consensus of Chinese Association for the Study of Pain on the non-opioid analgesics for chronic musculoskeletal pain

World J Clin Cases. 2021 Mar 26;9(9):2068-2076. doi: 10.12998/wjcc.v9.i9.2068.

Abstract

Chronic musculoskeletal pain (CMP) is a common occurrence in clinical practice and there are a variety of options for the treatment of it. However, the pharmacological therapy is still considered to be a primary treatment. The recent years have witnessed the emergence of opioid crisis, yet there are no relevant guidelines on how to treat CMP with non-opioid analgesics properly. The Chinese Medical Association for the Study of Pain convened a panel meeting to develop clinical practice consensus for the treatment of CMP with non-opioid analgesics. The purpose of this consensus is to present the application of nonsteroidal anti-inflammatory drugs, serotonin norepinephrine reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, muscle relaxants, ion channel drugs and topical drugs in CMP.

Keywords: Chronic musculoskeletal pain; Cyclooxygenase; Nociceptor; Non-opioid analgesics; Nonsteroidal anti-inflammatory drugs; Noradrenaline reuptake inhibitor.

Publication types

  • Review